Positive Long-term Outcomes with HeartFlow FFRCT and Plaque Analysis Demonstrated in ADVANCE-DK Registry at TCT 2024
27 oct. 2024 08h15 HE
|
HeartFlow Holding, Inc.
— Data confirm the use of FFRCT and Plaque Analysis helps assess long-term risks, informing more personalized and effective treatment plans for patients with coronary artery disease -– FFRCT further...
HeartFlow to Present Latest Data on AI-Enabled Coronary Artery Disease Management at TCT 2024
14 oct. 2024 08h00 HE
|
HeartFlow Holding, Inc.
Long-term outcomes data from ADVANCE-DK Registry with HeartFlow FFRCT and Plaque Analysis and ongoing clinical studies highlighting CCTA and FFRCT diagnostic pathway to be discussed in six...
TCT 2023: HeartFlow Presents Clinical Data Featuring First Solution Offering Lesion-Specific Insights
25 oct. 2023 11h00 HE
|
HeartFlow Holding, Inc.
New Clinical Data Support Use of Lesion-Specific FFRCT for Diagnosis and Treatment of Patients With Coronary Artery Disease
Rackspace Technology Launches Technical Career Track Program
10 mars 2022 11h05 HE
|
Rackspace Technology, Inc.
SAN ANTONIO, March 10, 2022 (GLOBE NEWSWIRE) -- Rackspace Technology® (NASDAQ: RXT), a leading end-to-end, multicloud technology solutions company, today announced a revitalized Technical Career...
Amaranth Medical Initiates Clinical Trial of the Second-Generation FORTITUDE Bioresorbable Drug-Eluting Scaffold
16 sept. 2014 09h00 HE
|
Amaranth Medical, Inc.
MOUNTAIN VIEW, CA, Sept. 16, 2014 (GLOBE NEWSWIRE) -- Amaranth Medical, a
privately held medical device company, announced the initiation of
patient enrollment in multiple centers in Colombia, South...
Spectranetics' EXCITE ISR Data to Be Presented at Transcatheter Cardiovascular Therapeutics (TCT) Late-Breaking Clinical Trial Session in Washington, D.C.
10 sept. 2014 09h29 HE
|
The Spectranetics Corporation
COLORADO SPRINGS, Colo., Sept. 10, 2014 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (Nasdaq:SPNC) today announced that data from EXCITE ISR will be presented as a late-breaking clinical trial at...
Colibri Heart Valve Concludes Patient Enrollment in First-in-Human Study of Proprietary TAVI System in Dominican Republic
24 oct. 2013 08h00 HE
|
Colibri Heart Valve LLC
BROOMFIELD, CO, Oct. 24, 2013 (GLOBE NEWSWIRE) -- Colibri Heart Valve,
LLC, a privately held medical device company, announced that
patient enrollment has concluded in the first-in-human study of...